Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07006831 · ClinicalTrials.gov registry record
A Multicenter, Prospective Blood Collection Study in a Kidney Transplant Population
A clinical trial of Kidney Transplant and Kidney Disease, sponsored by Devyser.
- Recruiting
- Registry status
- 400
- Enrollment target
- 6
- Study locations
NCT07006831: Recruiting study of Kidney Transplant and Kidney Disease, sponsored by Devyser.
NCT07006831 is a study of Kidney Transplant and Kidney Disease that is actively recruiting participants, run by Devyser. The registered enrollment target is 400 participants, below the 1,885-participant average among 30 other Kidney Transplant trials with a reported enrollment target (79% lower). The trial reports 6 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07006831, a study of Kidney Transplant and Kidney Disease, is actively recruiting participants, sponsored by Devyser.
- RECRUITING
- Registry status
- 400 participants
- Enrollment target
- 6
- Study locations
Study Summary
The purpose of this research is to collect blood samples and data from kidney transplant patients. The samples and data will be used for research and development of non-invasive test to detect donor-derived cell-free DNA (dd-cfDNA) in kidney transplant patients to evaluate the status of the transplanted organ.
Primary Outcome
Collected samples will be used for research and development of a noninvasive in- vitro diagnostic test to detect donor-derived cell-free DNA (dd-cfDNA) in kidney transplant patients.
Conditions Studied
Study Locations (6)
California
- Scripps Health - San Diego
- University of California San Francisco - San Francisco
Georgia
- Piedmont Healthcare - Atlanta
Maryland
- University of Maryland Baltimore - Baltimore
Massachusetts
- Brigham & Women's Hospital - Boston
Utah
- University of Utah - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2025-11-14 |
| Est. Completion | 2027-03 |
What NCT07006831 shows while recruiting
NCT07006831 is an observational study that tracks outcomes without assigning an intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, below the 1,885-participant average among 30 other Kidney Transplant trials with a reported enrollment target (79% lower).
The record links to 6 conditions, with Kidney Transplant appearing as the primary indexed condition, and to 0 interventions.
NCT07006831 lists 6 locations in 5 states (California, Georgia, Maryland).
Frequently Asked Questions
What is clinical trial NCT07006831 about?
NCT07006831 is a clinical study titled "A Multicenter, Prospective Blood Collection Study in a Kidney Transplant Population". The purpose of this research is to collect blood samples and data from kidney transplant patients. The samples and data will be used for research and development of non-invasive test to detect donor-derived cell-free DNA (dd-cfDNA) in kidney transplant patients to evaluate the status of the transpla...
What is the current status of trial NCT07006831?
This trial is currently recruiting. The enrollment target is 400 participants. The study started on 2025-11-14. Estimated completion is 2027-03.
What conditions does trial NCT07006831 study?
This clinical trial studies the following conditions: Kidney Transplant, Kidney Disease, Renal Function, Cell-free DNA, Transplant Recipient.
Who is sponsoring clinical trial NCT07006831?
This trial is sponsored by Devyser, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07006831 being conducted?
This trial has 6 study locations across California, Georgia, Maryland, Massachusetts, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Kidney Transplant
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07006831's enrollment target sits among peer trials
400 5th of 30 higher than 26 of 30 other Kidney Transplant trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Kidney Transplant trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Safety and Tolerability of Vertebral Bone Marrow-derived Mesenchymal Stem Cells (BM-MSC) in Real World Scenarios of Patients With Chronic Kidney Disease (CKD)
RECRUITING
-
Social Support Counseling Intervention for Kidney Transplant Candidates
RECRUITING · NA
-
Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation
RECRUITING · Phase 3
-
An Efficacy, Safety, and Tolerability Study of VX-880 in Participants With Type 1 Diabetes With a Kidney Transplant
RECRUITING · Phase 3
-
Advancing Transplantation Outcomes in Children
RECRUITING · Phase 2
-
Adipose-derived MSC to Treat Rejection in Kidney Transplant Recipients
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI